When IL‐17 inhibitors fail: Real‐life evidence to switch from secukinumab to adalimumab or ustekinumab-Reference-Cited by-同舟云学术

When IL‐17 inhibitors fail: Real‐life evidence to switch from secukinumab to adalimumab or ustekinumab

Published:2018-12-21 Issue:2 Volume:32 Page:e12793
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Damiani Giovanni¹²³⁴^ORCID,Conic Rosalynn R. Z.⁴,de Vita Valerio¹,Costanzo Antonio⁵,Regazzini Roberto⁶,Pigatto Paolo D. M.²³,Bragazzi Nicola L.⁷,Pacifico Alessia⁸^ORCID,Malagoli Piergiorgio⁹

Affiliation:

1. Young Dermatologists Italian Network (YDIN)Centro Studi GISED Bergamo Italy

2. Clinical DermatologyIRCCS Galeazzi Orthopaedic Institute Milan Italy

3. Department of Biomedical, Surgical and Dental SciencesUniversity of Milan Milan Italy

4. Department of DermatologyCase Western Reserve University Cleveland Ohio

5. Unit of DermatologyIRCCS Humanitas Research Hospital Rozzano Milan Italy

6. Dermatology UnitAzienda Ospedaliera Sant'Anna Como Italy

7. School of Public Health, Department of Health Sciences (DISSAL)University of Genoa Genoa Italy

8. San Gallicano Dermatological Institute, IRCCS Rome Italy

9. Dermatology UnitAzienda Ospedaliera San Donato Milanese Milan Italy

Funder

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.12793

Reference15 articles.

1. Outcomes assessment of hepatitis C virus-positive psoriatic patients treated using pegylated interferon in combination with ribavirin compared to new Direct-Acting Antiviral agents

2. Switching between TNF inhibitors in psoriatic arthritis: data from the NOR-DMARD study

3. The economic burden of psoriasis: a systematic literature review

4. Liver Illness and Psoriatic Patients

5. Drug survival of secukinumab in real-world plaque psoriasis patients: A 52-week, multicenter, retrospective study

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. T cells promote distinct transcriptional programs of cutaneous inflammatory disease in human skin structural cells;2024-07-31

2. Identification of angiogenesis-related genes and molecular subtypes for psoriasis based on random forest algorithm;Clinical and Experimental Immunology;2024-06-28

3. Six-Month Real-World Study to Assess the Effectiveness of Ixekizumab After Switching from IL-23 Inhibitors and Other Biologic Therapies: The CorEvitas Psoriasis Registry;Drugs - Real World Outcomes;2024-06-24

4. Multi‐failure psoriasis patients: characterization of the patients and response to biological therapy in a multicenter Italian cohort;International Journal of Dermatology;2024-01-05

5. Interclass Switch between IL17 and IL23 Inhibitors in Psoriasis: A Real-Life, Long-Term, Single-Center Experience;Journal of Clinical Medicine;2023-12-05